Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
Up-to-date access to technology licensing opportunities worldwide.
- In-licensing
- Browse
Licensing opportunities
Seeking opportunities for OTC consumer healthcare products in the area of oral and topical pain relief products. More
NCEs for innovative therapeutic targets in inflammatory/immunologic diseases. More
Seeking licensing opportunities for the UK hospital market More
Delivery technologies for oral, topical and transdermal products which could be applicable to the consumer healthcare arena More
Fresenius Kabi is looking for in-licensing opportunities in infusion therapy and clinical nutrition, e.g. in the area of i.v. drugs, more specifically in the areas of pain management/CNS, anesthesia, anti-infectives, inflammation and oncology. More
Pharmaceuticals for pain and wound healing for hospital use More
Seeking opportunities for consumer healthcare products and molecules with Rx-to-OTC switch potential
OTC products ready for registration or in late stage development and molecules with Rx-to-OTC switch potential. More
Acquisition of established pharmaceuticals in the UK market More
Therapeutic drugs in late stage development (marketed, registered or in clinical trials) are sought to complement our product portfolio. More
TPU is constantly seeking to acquire products/technologies that complement the company's pipeline. And for companies looking for a product-life-cycle extension or a new drug delivery system, Teikoku Pharma is the strategic partner of choice. More
Your selection
Browse By
- Therapeutic target
- Age-related disorders (other)
- Amyotrophic lateral sclerosis
- CNS (other)
- Neurodegenerative disorders
- Neurological
- Pain
- Psychiatric
- Subarachnoid hemorrhage
- Traumatic brain injury
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us